| 反应停治疗难治性多发性骨髓瘤11例临床报告 |
| |
| 引用本文： | 吴德沛,孙爱宁,唐晓文,傅铮铮,苗瞄,李建勇,夏学鸣,林宝爵. 反应停治疗难治性多发性骨髓瘤11例临床报告[J]. 苏州大学学报(自然科学版), 2000, 20(11): 997-998 |
| |
| 作者姓名： | 吴德沛 孙爱宁 唐晓文 傅铮铮 苗瞄 李建勇 夏学鸣 林宝爵 |
| |
| 作者单位： | 苏州大学附属第一医院血液科,江苏省血液研究所,苏州,215006 |
| |
| 摘 要： | 目的 为观察反应停治疗难治性浆细胞肿瘤的有效性和毒性。方法 共 11例难治性浆细胞肿瘤入选。每晚服用反应停 2 0 0～ 40 0mg。结果 1例因服药未满一月而删除 ,10例中部分缓解 3例 ,进步 3例 ,无效 4例。副作用可以耐受 ,便秘 (7/10 )最常见。结论 30 0～ 40 0mg/日反应停治疗难治性多发性骨髓瘤安全有效
|
| 关 键 词： | 反应停 治疗 多发性骨髓瘤 |
Clinical Report on Thalidomide for Treatment of 11 Cases Refractory Multiple Myeloma |
| |
| Wu Depei Sun Aining Tang Xiaowei et al. Clinical Report on Thalidomide for Treatment of 11 Cases Refractory Multiple Myeloma[J]. Suzhou University Journal of Medical Science, 2000, 20(11): 997-998 |
| |
| Authors: | Wu Depei Sun Aining Tang Xiaowei et al |
| |
| Abstract: | Objective To investigate the efficacy and toxicity on thalidomide in the treatment of refractory plasma cell neoplasms. Method Oral thalidomide was given to 11 patients at doses of 200-400mg every evening. Results Among the 10 evaluative patients three achieved partial remission (PR) ,3 improved and 4 had no effect. Side effects could been tolerate and the most common one was constipation (7/10). Conclusion Thalidomide at doses of 300-400mg/d for the treatment of refractory plasma cell neoplasms is safe and effective . |
| |
| Keywords: | thalidomide treatment multiple myeloma |
|
|
